Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 205.09

+3.0%

2:07 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WTDEC who wrote (19436)	4/22/1998 11:33:00 PM
From: Henry Niman	Read Replies (1) of 32384

W, Your expectations are too high. There is human data on Tamoxifen and Evista. Droloxifene just started its prevention trial so there is no data indicating that it is as good as Evista, Tamoxifen, or any of the other SERMs that have yet to be tested for breast cancer prevention in humans.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next